FBI Probes Jim Irsay Death Over Prescription Drugs, Ketamine Use and Doctor Relationship: Report

FBI Investigation into Jim Irsay’s Death and Drug Use

Federal authorities have launched a detailed investigation into the death of Jim Irsay, the longtime owner of the Indianapolis Colts, centering on his use of prescription medications, ketamine treatments, and his connection with a California-based addiction doctor. According to reports from The Washington Post, the FBI issued a federal grand jury subpoena earlier this month to obtain records related to Irsay’s death, his alleged consumption of both legal and illegal drugs, and his relationship with Dr. Harry Haroutunian, who treated Irsay in the months leading up to his death.

The investigation also included several days of activity in Indianapolis, where federal agents sought additional information. The FBI has declined to comment publicly on the probe. Meanwhile, Colts Chief Legal Officer Dan Emerson confirmed the existence of subpoenas but clarified that neither he nor the Colts organization or its employees have been directly served with any documents related to the investigation.

Background on Jim Irsay’s Health and Medical Treatment

Jim Irsay, who took ownership of the Colts in 1997, passed away in May at the age of 65. His death certificate, signed by Dr. Haroutunian, cites cardiac arrest caused by acute pneumonia, with underlying heart conditions contributing to his passing. Notably, no official autopsy was performed after his death.

Throughout his life, Irsay faced numerous health challenges, including battles with drug and alcohol addiction. He openly admitted to having entered rehabilitation facilities at least 15 times. In January 2024, the Colts announced that Irsay was being treated for a severe respiratory illness. By February, Irsay shared on social media that he was “on the mend,” signaling some recovery progress.

However, in December 2023, police responded to a call at Irsay’s home in the early morning hours and found him unresponsive in bed, describing the incident as a “suspected overdose.” Irsay later disputed the overdose claim, telling local media that the reports were unfair and inaccurate, attributing the rumors to his past public struggles with substance abuse.

Role of Prescription Drugs and Ketamine in Irsay’s Final Months

The Washington Post’s investigation revealed that Dr. Haroutunian allegedly prescribed over 200 opioid pills to Irsay before the December 2023 incident. The reports also indicate that Irsay received ketamine treatments during a period of relapse prior to his death. The overdose events reportedly occurred both at his Indianapolis residence and a Miami rental property.

The Colts organization addressed the ongoing investigation in a public statement, acknowledging awareness of the probe but emphasizing that they have not been contacted by the FBI or served with any subpoenas at this time.

Irsay’s history with legal troubles related to substance use includes a 2014 arrest for operating while intoxicated (OWI), which resulted in a six-game suspension and a $500,000 fine from the NFL. Irsay has suggested that his treatment was influenced by his status as a White billionaire.

Jim Irsay’s Legacy and Impact on the NFL

Jim Irsay’s family has owned the Colts since 1972, when his father purchased the team for $12 million while they were still based in Baltimore. The franchise relocated to Indianapolis in 1984. Irsay served as the team’s general manager from 1982 until 1996 and became the NFL’s youngest owner at age 37 after his father’s death in 1997.

Under Irsay’s leadership, the Colts achieved significant success, winning 258 games—the fourth-most in the NFL during his tenure. The team secured 10 division titles, appeared in two Super Bowls with a 1-1 record, and made the playoffs 18 times. His impact on the organization and the league was profound, shaping the Colts into a perennial contender.

What’s Next in the FBI Probe?

The FBI’s investigation into Jim Irsay’s death is ongoing, with federal agents continuing to gather evidence regarding his prescription drug use, ketamine treatments, and medical care. The involvement of Dr. Haroutunian, who signed Irsay’s death certificate and treated him during his final months, remains a key focus.

As the probe unfolds, more details are expected to emerge about the circumstances surrounding Irsay’s death and whether any medical or legal misconduct occurred. The Colts organization and Irsay’s family have yet to release detailed comments beyond acknowledging the investigation.

Conclusion

The FBI’s probe into Jim Irsay’s death highlights the complex issues surrounding prescription drug use, addiction treatment, and medical oversight in high-profile cases. As more information becomes available, it will shed light on the factors that contributed to the tragic passing of the Indianapolis Colts owner. For those interested in staying updated on this developing story and other sports news, be sure to follow trusted news sources and subscribe to newsletters that provide in-depth coverage. Stay informed and engaged to understand the full scope of this investigation.